#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast cancer metastatic Hyperadrenocorticism White matter lesion Transferrin decreased Salivary gland cancer Noonan syndrome Cystic fibrosis gastrointestinal disease Astrocytoma Cutaneous calcification Osteosarcoma recurrent Uterine leiomyosarcoma Congenital pseudarthrosis Vascular calcification Peritoneal neoplasm Lennox-Gastaut syndrome More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Treatment Niemann-Pick disease – Diagnostics Chondrosarcoma metastatic Rhabdoid tumour Paraneoplastic neurological syndrome – Life with Disease Angelman’s syndrome – Treatment Methylmalonic acidaemia – Basic Information Castleman’s disease Erdheim-Chester disease – Basic Information Leiomyosarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IBUZATRELVIR IHMA-2121771-1 Ranitidine Hydrochloride MZE829 Everolimus Cx-039776 SAR443820 Dorocubicel ARI0008 SONLICROMANOL HYDROCHLORIDE Palonosetron Hydrochloride Norepinephrine Gs-4182 BUMETANIDE Nusinersen Risperidone Letrozole Zoledronic Acid Lactulose Patritumab Deruxtecan More therapies…

    Learn about Your Condition

    Nodal osteoarthritis Trisomy 21 Syphilis Laparotomy Brain neoplasm malignant Corneal dystrophy Rectosigmoid cancer Prodromal Alzheimer's disease Optic glioma Traumatic pain Acquired haemophilia Lymphoma Thromboangiitis obliterans Vascular graft thrombosis Epiphysiolysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Envudeucitinib
    • Apremilast
    Austria Estonia France Germany Hungary Latvia +3

  • Study on the Effectiveness of Clindamycin and Tretinoin Gel for Treating Acne in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acne
    Investigated Drugs:
    • Clindamycin
    • Tretinoin
    Greece

  • Study on the Effects of IDP-118 Lotion (Tazarotene and Halobetasol Propionate) for Children with Moderate to Severe Plaque Psoriasis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • HALOBETASOL PROPIONATE
    • TAZAROTENE
    Poland

  • Study Comparing CT-P55 and Secukinumab for Moderate to Severe Plaque Psoriasis Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Secukinumab
    Poland

  • Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

    Not recruiting

    3 1
    Investigated Drugs:
    • Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
    Austria Czechia France Germany Hungary Italy +4

  • Study of L-Annamycin Treatment for Patients with Previously Treated Metastatic Soft Tissue Sarcoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Annamycin
    Poland
Previous Page
1 … 35 36 37 38 39 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!